New dissolving paracetamol tablet put to the test

NCT ID NCT06855576

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether a new paracetamol tablet that dissolves in the mouth (orodispersible) works the same as two existing paracetamol tablets. Healthy adults aged 18 to 55 take a single dose of each tablet on separate days, and researchers measure how much paracetamol gets into the blood. The goal is to see if the new tablet is a suitable alternative for people who have trouble swallowing pills.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Paracetamol
What this could lead to
If successful, this could provide a new, easier-to-take form of paracetamol that dissolves in the mouth.
What could go wrong
This is an early-phase study in healthy volunteers, so results may not apply to people with pain or fever. The new tablet may not be absorbed identically.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fever Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SocraTec R&D GmbH

    Erfurt, Thuringia, 99084, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.